相关实验视频

Updated: Sep 16, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

多omics分析通过在肝细胞癌中整合门德尔随机化和机器学习来识别与SNP相关的免疫相关的特征

Qingyan Kou¹, Zhichao Wu¹, Wenbin Zhao¹

¹Department of General Surgery, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), Qingdao, China.

Scientific reports

|July 4, 2025

概括

这项研究开发了一种新的riskScore模型,用于预测肝细胞癌 (HCC) 患者的结果. 该模型整合了遗传和免疫数据,改善了患者分层,并指导化疗决策,以便更好地治疗HCC.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
免疫学免疫学免疫学

背景情况:

肝细胞癌 (HCC) 是一个重大的全球健康挑战,死亡率高,治疗选择有限.
准确的患者分层和个性化疗法非常重要,因为HCC的复杂分子和免疫特征.

研究的目的:

确定影响HCC预后的关键基因,并开发一个强大的预后模型.
整合遗传,临床和免疫数据,以改善HCC患者分层和治疗预测.

主要方法:

使用了大规模的基因表达数据 (TCGA,GSE54236) 和eQTL GWAS数据.
应用孟德尔随机化,生存分析和101机器学习算法来构建预后模型.
通过生存分析,药物敏感性预测和体外检测验验证了riskScore模型.

主要成果:

确定了27个候选基因,其中16个被归类为高风险,并开发了一个具有出色预后性能 (C指数>0.7) 的风险Score模型.
高风险患者的预后较差,免疫细胞透率增加 (T细胞,中性粒细胞),对特定化学疗法 (5-Fluorouracil,Paclitaxel) 的敏感性更大.
高风险群体中经常出现TP53和MUC16突变;SLC16A3和STRBP基因促进HCC细胞的增殖和入侵.

结论:

开发的riskScore模型有效地根据综合的遗传和免疫因素对HCC患者进行分层.
该模型显示了在患者分层和优化肝细胞癌化疗策略的临床应用的潜力.
像SLC16A3和STRBP这样的关键基因在HCC进展中发挥着重要作用,提供了潜在的治疗点.

关键词:

化学疗法敏感性化学疗法敏感性基因突变是一种基因突变.在HCC中,HCC是HCC,HCC是HCC.免疫检查站检查站免疫微环境是一个微环境.在这里,我们可以看到MR MR.预测预测预测预测的时间.风险评分风险评分

更多相关视频

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...